300804 广康生化
已收盘 12-17 15:00:00
资讯
新帖
简况
12月17日广康生化发布公告,股东减持1.02万股
证券之星 · 18:01
12月17日广康生化发布公告,股东减持1.02万股
广康生化(300804)披露关于控股股东、实际控制人部分股份解除质押的公告,11月27日股价上涨0.7%
证券之星 · 11-27
广康生化(300804)披露关于控股股东、实际控制人部分股份解除质押的公告,11月27日股价上涨0.7%
广康生化(300804)股东蔡丹群质押100万股,占总股本1.35%
证券之星 · 11-11
广康生化(300804)股东蔡丹群质押100万股,占总股本1.35%
广康生化(300804)股东蔡丹群质押100万股,占总股本1.35%
证券之星 · 11-05
广康生化(300804)股东蔡丹群质押100万股,占总股本1.35%
广康生化(300804)2025年三季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 10-25
广康生化(300804)2025年三季报简析:营收净利润同比双双增长,盈利能力上升
广康生化(300804)披露使用部分闲置募集资金暂时补充流动资金公告,10月23日股价上涨0.13%
证券之星 · 10-23
广康生化(300804)披露使用部分闲置募集资金暂时补充流动资金公告,10月23日股价上涨0.13%
广康生化(300804.SZ):前三季净利润3484.8万元 同比增长47.1%
中金财经 · 10-23
广康生化(300804.SZ):前三季净利润3484.8万元 同比增长47.1%
股市必读:广康生化(300804)今年截至10月17日累计跌幅已超20%
证券之星 · 10-20
股市必读:广康生化(300804)今年截至10月17日累计跌幅已超20%
广康生化(300804)披露归还全部暂时补充流动资金的闲置募集资金的公告,10月17日股价下跌2.54%
证券之星 · 10-17
广康生化(300804)披露归还全部暂时补充流动资金的闲置募集资金的公告,10月17日股价下跌2.54%
广康生化(300804)披露特定股东减持股份预披露公告,10月14日股价下跌1.51%
证券之星 · 10-14
广康生化(300804)披露特定股东减持股份预披露公告,10月14日股价下跌1.51%
广康生化最新公告:股东共青城瑞宏凯银壹号股权投资基金合伙企业计划减持不超2.68%股份
证券之星 · 10-14
广康生化最新公告:股东共青城瑞宏凯银壹号股权投资基金合伙企业计划减持不超2.68%股份
股市必读:广康生化(300804)9月19日披露最新机构调研信息
证券之星 · 09-22
股市必读:广康生化(300804)9月19日披露最新机构调研信息
广康生化:已布局多个面向南美市场的产品
证券之星 · 09-17
广康生化:已布局多个面向南美市场的产品
广康生化最新公告:股东拟合计减持不超过1.7973%公司股份
证券之星 · 09-14
广康生化最新公告:股东拟合计减持不超过1.7973%公司股份
9月8日广康生化发布公告,股东减持222万股
证券之星 · 09-08
9月8日广康生化发布公告,股东减持222万股
广康生化:以绿色创新为驱动推动高质量发展
证券之星 · 08-26
广康生化:以绿色创新为驱动推动高质量发展
广康生化(300804)2025年中报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 08-23
广康生化(300804)2025年中报简析:营收净利润同比双双增长,盈利能力上升
图解广康生化中报:第二季度单季净利润同比增长177.57%
证券之星 · 08-21
图解广康生化中报:第二季度单季净利润同比增长177.57%
广康生化股价小幅上扬 一季度现金流同比增382%
金融界 · 08-18
广康生化股价小幅上扬 一季度现金流同比增382%
广康生化:减持进展在时间过半或数量过半时已不再强制要求披露
证券之星 · 08-18
广康生化:减持进展在时间过半或数量过半时已不再强制要求披露
暂无数据
公司概况
公司名称:
广东广康生化科技股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2023-06-27
主营业务:
广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。公司的主要产品是联苯肼酯、甲氧虫酰肼等杀虫剂;噻呋酰胺、克菌丹、灭菌丹、土菌灵、萎锈灵等杀菌剂;甜菜宁、甜菜安、乙氧呋草黄等除草剂。公司是广东省内主要的农药原药生产企业,是中国农药发展与应用协会理事单位、中国石油化工优秀民营企业、中国农药工业协会AA级信用企业、广东省创新型企业、广东省知识产权贯标认证企业。
发行价格:
42.45
{"stockData":{"symbol":"300804","market":"SZ","secType":"STK","nameCN":"广康生化","latestPrice":33.93,"timestamp":1765955025000,"preClose":33.54,"halted":0,"volume":1014831,"delay":0,"changeRate":0.0116,"floatShares":27500000,"shares":74000000,"eps":0.6195,"marketStatus":"已收盘","change":0.39,"latestTime":"12-17 15:00:00","open":33.49,"high":33.97,"low":32.77,"amount":33896200,"amplitude":0.0358,"askPrice":33.93,"askSize":2,"bidPrice":33.87,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.6195,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":33.54,"symbolType":"stock","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":36.89,"lowLimit":30.19,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":74000000,"isCdr":false,"pbRate":1.82,"roa":"--","peRate":54.769976,"roe":"2.6%","epsLYR":0.47,"committee":-0.813187,"marketValue":2511000000,"turnoverRate":0.0369,"status":0,"floatMarketCap":933000000},"requestUrl":"/m/hq/s/300804/tweets","defaultTab":"tweets","newsList":[{"id":"2592996587","title":"12月17日广康生化发布公告,股东减持1.02万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2592996587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592996587?lang=zh_cn&edition=full","pubTime":"2025-12-17 18:01","pubTimestamp":1765965690,"startTime":"0","endTime":"0","summary":"证券之星消息,12月17日广康生化发布公告《广康生化:关于特定股东减持股份计划期限届满暨实施情况的公告》,其股东深圳市华拓至远叁号投资企业(有限合伙)于2025年11月3日合计减持1.02万股,占公司目前总股本的0.0138%,变动期间该股股价上涨3.8%,截止11月3日收盘报40.71元。股东增减持详情见下表:根据广康生化2025年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700028768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2586225405","title":"广康生化(300804)披露关于控股股东、实际控制人部分股份解除质押的公告,11月27日股价上涨0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586225405","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586225405?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:32","pubTimestamp":1764253949,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘,广康生化报收于35.72元,较前一交易日上涨0.7%,最新总市值为26.43亿元。该股当日开盘35.68元,最高36.06元,最低35.54元,成交额达2017.36万元,换手率为2.05%。近日,广东广康生化科技股份有限公司发布公告,公司控股股东、实际控制人蔡丹群先生已于2025年11月26日将其持有的200万股公司股份解除质押,占其所持股份比例7.75%,占公司总股本比例2.70%,质权人为深圳市高新投融资担保有限公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2582350680","title":"广康生化(300804)股东蔡丹群质押100万股,占总股本1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582350680","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582350680?lang=zh_cn&edition=full","pubTime":"2025-11-11 18:28","pubTimestamp":1762856912,"startTime":"0","endTime":"0","summary":"证券之星消息,广康生化11月11日公开信息显示,股东蔡丹群向兴业银行股份有限公司广州分行合计质押100.0万股,占总股本1.35%。质押详情见下表:截止本公告日,股东蔡丹群已累计质押股份400.0万股,占其持股总数的15.49%。广康生化主营业务:农药原药、中间体、制剂的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100032462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2581728932","title":"广康生化(300804)股东蔡丹群质押100万股,占总股本1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581728932","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581728932?lang=zh_cn&edition=full","pubTime":"2025-11-05 18:35","pubTimestamp":1762338930,"startTime":"0","endTime":"0","summary":"证券之星消息,广康生化11月5日公开信息显示,股东蔡丹群向深圳市中小担非融资性担保有限公司合计质押100.0万股,占总股本1.35%。质押详情见下表:截止本公告日,股东蔡丹群已累计质押股份300.0万股,占其持股总数的11.62%。广康生化主营业务:农药原药、中间体、制剂的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500034084.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2578525732","title":"广康生化(300804)2025年三季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2578525732","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578525732?lang=zh_cn&edition=full","pubTime":"2025-10-25 06:10","pubTimestamp":1761343822,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期广康生化发布2025年三季报。截至本报告期末,公司营业总收入5.5亿元,同比上升13.53%,归母净利润3484.84万元,同比上升47.09%。按单季度数据看,第三季度营业总收入1.51亿元,同比下降9.41%,第三季度归母净利润583.45万元,同比上升236.87%。本报告期广康生化盈利能力上升,毛利率同比增幅8.18%,净利率同比增幅30.95%。为应对持续增长的客户需求,公司正积极推进灭菌丹扩产计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102500005750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"gpt_icon":0},{"id":"2577374435","title":"广康生化(300804)披露使用部分闲置募集资金暂时补充流动资金公告,10月23日股价上涨0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577374435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577374435?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:28","pubTimestamp":1761211704,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘,广康生化报收于39.5元,较前一交易日上涨0.13%,最新总市值为29.23亿元。该股当日开盘39.75元,最高39.76元,最低39.09元,成交额达4460.94万元,换手率为4.11%。根据公司近日发布的公告,广东广康生化科技股份有限公司于2025年10月23日以通讯表决方式召开第四届董事会第三次会议,审议通过《关于使用部分闲置募集资金暂时补充流动资金的议案》。公告称,公司拟使用不超过10,000.00万元闲置募集资金暂时补充流动资金,使用期限不超过12个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300027159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2577371700","title":"广康生化(300804.SZ):前三季净利润3484.8万元 同比增长47.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577371700","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577371700?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:07","pubTimestamp":1761210437,"startTime":"0","endTime":"0","summary":"格隆汇10月23日丨广康生化(300804.SZ)公布三季度报告,前三季营业收入5.5亿元,同比增长13.53%,归属于上市公司股东的净利润3484.8万元,同比增长47.1%,归属于上市公司股东的扣除非经常性损益的净利润3241万元,同比增长169.48%。\r\n\r\n \r\n\r\n 【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱:news_center@staff.hexun.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251023/31730985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300804"],"gpt_icon":0},{"id":"2576008961","title":"股市必读:广康生化(300804)今年截至10月17日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576008961","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576008961?lang=zh_cn&edition=full","pubTime":"2025-10-20 02:40","pubTimestamp":1760899221,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘,广康生化报收于37.16元,下跌2.54%,换手率4.99%,成交量1.37万手,成交额5172.5万元。交易信息汇总股价提醒10月17日广康生化收盘报37.16元,跌2.54%,当日成交137.25万元。该股已连续4日下跌,当年累计跌幅21.86%。前10个交易日中,主力资金累计净流出2333.63万元,股价累计下跌4.37%;融资余额累计减少478.1万元,融券余量累计增加0股。公告日期为2025年10月17日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000001003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2576723059","title":"广康生化(300804)披露归还全部暂时补充流动资金的闲置募集资金的公告,10月17日股价下跌2.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576723059","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576723059?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:33","pubTimestamp":1760711591,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘,广康生化报收于37.16元,较前一交易日下跌2.54%,最新总市值为27.5亿元。截至本公告披露日,公司已将上述用于暂时补充流动资金的10,000.00万元闲置募集资金全部归还至募集资金专用账户,并已及时告知保荐机构及保荐代表人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700038566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2575212537","title":"广康生化(300804)披露特定股东减持股份预披露公告,10月14日股价下跌1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575212537","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575212537?lang=zh_cn&edition=full","pubTime":"2025-10-14 23:01","pubTimestamp":1760454076,"startTime":"0","endTime":"0","summary":"截至2025年10月14日收盘,广康生化报收于39.18元,较前一交易日下跌1.51%,最新总市值为28.99亿元。该股当日开盘39.55元,最高39.99元,最低39.09元,成交额达5078.44万元,换手率为4.67%。其中集中竞价减持不超过740,000股,大宗交易减持不超过1,240,000股。减持期间为2025年10月18日至2026年1月17日。该股东严格履行此前作出的承诺,不属于公司控股股东或实际控制人,减持不会导致控制权变更,不影响公司治理结构及持续经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400065839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2575629128","title":"广康生化最新公告:股东共青城瑞宏凯银壹号股权投资基金合伙企业计划减持不超2.68%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2575629128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575629128?lang=zh_cn&edition=full","pubTime":"2025-10-14 19:01","pubTimestamp":1760439694,"startTime":"0","endTime":"0","summary":"广康生化(300804.SZ)公告称,股东共青城瑞宏凯银壹号股权投资基金合伙企业(有限合伙)计划自公告披露日起三个交易日后的三个月内,通过集中竞价、大宗交易方式合计减持公司股份不超过198万股,即不超过公司总股本的2.6757%。减持价格不低于经除权除息等因素调整后的发行价。减持计划符合相关法律法规及规范性文件的规定,减持计划的实施不会导致公司控制权发生变更。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400058758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2569220780","title":"股市必读:广康生化(300804)9月19日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2569220780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569220780?lang=zh_cn&edition=full","pubTime":"2025-09-22 03:42","pubTimestamp":1758483735,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘,广康生化报收于38.82元,下跌0.46%,换手率5.05%,成交量1.39万手,成交额5425.02万元。来自机构调研要点:公司回应股价下跌与股东减持,称相关股东为长期“耐心资本”,减持系正常财务安排,管理层对公司长期发展充满信心。随着产能释放,克菌丹和灭菌丹全球市场份额及竞争力有望增强。公司已在招股说明书中披露上市后三年内股价稳定预案,若触发条件将严格执行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200001193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2568499651","title":"广康生化:已布局多个面向南美市场的产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2568499651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568499651?lang=zh_cn&edition=full","pubTime":"2025-09-17 20:52","pubTimestamp":1758113534,"startTime":"0","endTime":"0","summary":"关注到近期南美农药市场需求增长迅猛仍有上百亿的市场空间,特别是巴西等国家对高效、低毒农药的需求显著提升。公司高度重视南美等新兴市场的发展机遇,并已制定了针对性的市场拓展策略。目前,在现有生产基地及宜昌募投项目的规划中,公司已布局多个面向南美市场的产品。持续优化产品结构与品质:依托强大的原药合成与工艺研发能力,公司不断推进产品结构优化和品质提升,契合南美市场对高效低毒农药的需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700038281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2567158287","title":"广康生化最新公告:股东拟合计减持不超过1.7973%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2567158287","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567158287?lang=zh_cn&edition=full","pubTime":"2025-09-14 16:00","pubTimestamp":1757836859,"startTime":"0","endTime":"0","summary":"广康生化(300804.SZ)公告称,股东共青城华拓至盈贰号投资合伙企业(有限合伙)和深圳市华拓至远叁号投资企业(有限合伙)计划自公告披露日起3个交易日后的3个月内,通过集中竞价、大宗交易方式合计减持不超过1,330,000股,即不超过公司总股本的1.7973%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400003539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2565961689","title":"9月8日广康生化发布公告,股东减持222万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2565961689","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565961689?lang=zh_cn&edition=full","pubTime":"2025-09-08 20:01","pubTimestamp":1757332906,"startTime":"0","endTime":"0","summary":"证券之星消息,9月8日广康生化发布公告《广康生化:关于特定股东减持股份计划期限届满暨实施完毕的公告》,其股东深圳市华拓至远叁号投资企业、深圳市华拓至远贰号投资企业、共青城华拓至盈贰号投资合伙企业、深圳市华拓至远投资企业于2025年6月9日至2025年9月8日间合计减持222.0万股,占公司目前总股本的3.0%,变动期间该股股价下跌11.64%,截止9月8日收盘报41.75元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800029678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0},{"id":"2562272318","title":"广康生化:以绿色创新为驱动推动高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2562272318","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562272318?lang=zh_cn&edition=full","pubTime":"2025-08-26 08:57","pubTimestamp":1756169828,"startTime":"0","endTime":"0","summary":"证券之星消息,广康生化08月25日在投资者关系平台上答复投资者关心的问题。尤其是像灭菌丹等产品打破了海外壁垒,帮助国内外农民用上了更多高效、可持续、环保的种植解决方案。请问公司内部决策层在进行路线出发点设计时,是否也认为,这类绿色技术不仅是业绩增长的引擎,更是对农民、股东、社会责任的一种回应坚守?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082600010943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"gpt_icon":0},{"id":"2561285444","title":"广康生化(300804)2025年中报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2561285444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561285444?lang=zh_cn&edition=full","pubTime":"2025-08-23 06:18","pubTimestamp":1755901102,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期广康生化发布2025年中报。截至本报告期末,公司营业总收入3.99亿元,同比上升25.55%,归母净利润2901.39万元,同比上升32.13%。按单季度数据看,第二季度营业总收入2.12亿元,同比上升51.54%,第二季度归母净利润1190.44万元,同比上升177.57%。本报告期广康生化盈利能力上升,毛利率同比增幅3.86%,净利率同比增幅6.27%。营业成本变动幅度为24.12%,原因:收入增长。财务费用变动幅度为114.02%,原因:利息支出及外汇贴现手续费增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082300006729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"gpt_icon":0},{"id":"2561463450","title":"图解广康生化中报:第二季度单季净利润同比增长177.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561463450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561463450?lang=zh_cn&edition=full","pubTime":"2025-08-21 17:36","pubTimestamp":1755769007,"startTime":"0","endTime":"0","summary":"证券之星消息,广康生化2025年中报显示,公司主营收入3.99亿元,同比上升25.55%;归母净利润2901.39万元,同比上升32.13%;扣非净利润2748.13万元,同比上升190.0%;其中2025年第二季度,公司单季度主营收入2.12亿元,同比上升51.54%;单季度归母净利润1190.44万元,同比上升177.57%;单季度扣非净利润1265.9万元,同比上升283.03%;负债率35.92%,投资收益388.19万元,财务费用753.01万元,毛利率23.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082100029976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"gpt_icon":0},{"id":"2560181560","title":"广康生化股价小幅上扬 一季度现金流同比增382%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560181560","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560181560?lang=zh_cn&edition=full","pubTime":"2025-08-18 23:30","pubTimestamp":1755531052,"startTime":"0","endTime":"0","summary":"广康生化最新股价报42.45元,较前一交易日上涨1.12%。公司2025年一季度经营活动现金流净额达422.42万元,同比增长382.43%。广康生化主营业务为农药兽药产品的研发、生产和销售,公司注册地位于广东省。2024年全年经营活动现金流净额为1434.48万元,同比增长14.79%。公司在互动平台表示,应收账款增长主要源于收入增长,目前海外客户应收账款均在合同约定的信用期内。公司将持续加强应收账款管理,提升资金周转效率。风险提示:股市有风险,投资需谨慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/18233052514903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300804","159399","BK0229"],"gpt_icon":0},{"id":"2560900759","title":"广康生化:减持进展在时间过半或数量过半时已不再强制要求披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2560900759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560900759?lang=zh_cn&edition=full","pubTime":"2025-08-18 20:51","pubTimestamp":1755521494,"startTime":"0","endTime":"0","summary":"证券之星消息,广康生化(300804)08月18日在投资者关系平台上答复投资者关心的问题。投资者提问:请问贵公司减持公告2025-022到现在已时间过半,这个减持计划执行情况是可以不公告吗?广康生化回复:您好!根据最新监管规定,减持进展在时间过半或数量过半时,已不再强制要求披露,因此公司未发布相关公告。欢迎您继续留意我们的后续公告。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081800032417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765971131879,"stockEarnings":[{"period":"1week","weight":-0.0504},{"period":"1month","weight":-0.1266},{"period":"3month","weight":-0.1665},{"period":"6month","weight":-0.4058},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.4867}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东广康生化科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"9599人(较上一季度减少10.79%)","perCapita":"2864股","listingDate":"2023-06-27","address":"广东省清远市英德市农用化工产业链专用基地(英德市沙口镇红丰管理区)","registeredCapital":"7400万元","survey":" 广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。公司的主要产品是联苯肼酯、甲氧虫酰肼等杀虫剂;噻呋酰胺、克菌丹、灭菌丹、土菌灵、萎锈灵等杀菌剂;甜菜宁、甜菜安、乙氧呋草黄等除草剂。公司是广东省内主要的农药原药生产企业,是中国农药发展与应用协会理事单位、中国石油化工优秀民营企业、中国农药工业协会AA级信用企业、广东省创新型企业、广东省知识产权贯标认证企业。","listedPrice":42.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广康生化,300804,广康生化股票,广康生化股票老虎,广康生化股票老虎国际,广康生化行情,广康生化股票行情,广康生化股价,广康生化股市,广康生化股票价格,广康生化股票交易,广康生化股票购买,广康生化股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}